MXPA02000378A - Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity. - Google Patents
Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity.Info
- Publication number
- MXPA02000378A MXPA02000378A MXPA02000378A MXPA02000378A MX PA02000378 A MXPA02000378 A MX PA02000378A MX PA02000378 A MXPA02000378 A MX PA02000378A MX PA02000378 A MXPA02000378 A MX PA02000378A
- Authority
- MX
- Mexico
- Prior art keywords
- aminoacid
- obesity
- extract
- soluble polymer
- product
- Prior art date
Links
- 241000195493 Cryptophyta Species 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000001014 amino acid Nutrition 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000006227 byproduct Substances 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 235000014633 carbohydrates Nutrition 0.000 title abstract 2
- 230000004060 metabolic process Effects 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000227647 Fucus vesiculosus Species 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229940046374 chromium picolinate Drugs 0.000 abstract 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 abstract 1
- -1 creame Substances 0.000 abstract 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 229960001518 levocarnitine Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention refers to the formulation or combination of four compounds, one of them being an aminoacid by-product known as L-carnitine or levocarnitine, the other element involved in the metabolism of carbohydrates known as chromium picolinate; the other, a soluble polymer known as sodium croscarmellose and the last one an extract of marine algae known as Fucus Vesiculosus, which are formulated in soft gelatine capsules, suspension, tablets, creame, gel, ointment and pills. The combination of these compounds offers a more powerful effect, by reducing weight rapidly; the composition being pharmaceutically employed for the treatment of obesity and related disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA02000378 MXPA02000378A (en) | 2002-01-11 | 2002-01-11 | Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA02000378 MXPA02000378A (en) | 2002-01-11 | 2002-01-11 | Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02000378A true MXPA02000378A (en) | 2004-05-21 |
Family
ID=34432065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02000378 MXPA02000378A (en) | 2002-01-11 | 2002-01-11 | Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MXPA02000378A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUA20162715A1 (en) * | 2016-04-19 | 2017-10-19 | Aesculapius Farm S R L | FORMULATION AND MANUFACTURING METHOD |
| RU2808338C1 (en) * | 2022-09-27 | 2023-11-28 | Общество с ограниченной ответственностью "Клиника психотерапии и восстановительной медицины" (ООО "Клиника психотерапии и восстановительной медицины") | Weight reduction method |
-
2002
- 2002-01-11 MX MXPA02000378 patent/MXPA02000378A/en not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUA20162715A1 (en) * | 2016-04-19 | 2017-10-19 | Aesculapius Farm S R L | FORMULATION AND MANUFACTURING METHOD |
| RU2808338C1 (en) * | 2022-09-27 | 2023-11-28 | Общество с ограниченной ответственностью "Клиника психотерапии и восстановительной медицины" (ООО "Клиника психотерапии и восстановительной медицины") | Weight reduction method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2481723A1 (en) | 5ht2c receptor modulators | |
| WO2008042688A3 (en) | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 | |
| NO20045301L (en) | Substituted 1,3-diphenylprop-2-en-1-one derivative, preparation and use thereof. | |
| TW200633730A (en) | Oral disintegrating dosage forms | |
| UA81615C2 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
| NO20050917L (en) | Thiomolybdate analogues and applications thereof | |
| CY1113475T1 (en) | Sodium-male Sodium for use in the treatment of migratory neoplastic diseases | |
| MX2010007083A (en) | Anti - retroviral combination. | |
| BRPI0410701A (en) | stabilized pharmaceutical | |
| HRP20250615T1 (en) | TRADIPITANT FOR USE IN THE TREATMENT OF GASTROPARESIS | |
| WO2004017998A3 (en) | Topical emulsion- gel composition comprising diclofenac sodium | |
| NO20082047L (en) | Slow release composition, process for its preparation and use thereof | |
| NO20035566D0 (en) | Prebiotic combination product | |
| WO2005027977A3 (en) | Diclofenac compositions for the treatment of skin disorders | |
| PT1425005E (en) | PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS LUMIRACOXIB | |
| CA2538905A1 (en) | Withanamide glycoside and compositions and methods of use thereof | |
| WO2005115414A3 (en) | Orally-administrable compositions comprising stable amorphous calcium carbonate | |
| IS6675A (en) | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, processes for their preparation and formulations containing them | |
| WO2005072056A3 (en) | Hsp therapy in conjunction with a low antigenicity diet | |
| UA90893C2 (en) | Oral dosage forms of gemcitabine derivatives | |
| ES2192136A1 (en) | Pharmaceutical compositions for the treatment or prevention of osteoporosis | |
| BR0206819A (en) | Use of il-18 inhibitors for treatment and / or prevention of heart disease. | |
| MXPA02000378A (en) | Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity. | |
| WO2008116737A3 (en) | Capsule containing plant preparations | |
| Klatz | The Official Anti-Aging Revolution: Stop the Clock Time is on Your Side for a Younger, Stronger, Happier You |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assignment | ||
| FA | Abandonment or withdrawal |